Search Results

3 search results found

March 5, 2020 | MIT News Office

Letter regarding MIT's response to the coronavirus disease
Decoy Therapeutics Inc.

Cambridge, MA

Biotechnology

The 21st century is experiencing epidemics and pandemics with increasing frequency, and the world needs new tools to combat these diseases. Decoy's platform engineers new pan-viral drugs that address both existing and new zoonotic viral threats. Our lead antiviral nasal spray has demonstrated... More

Keywords:

peptide conjugate, Antiviral, PPMO, PNA, fusion peptide, pan-viral family, SARS-CoV-2, RSV, self-administered drug
Fri, May 8, 2020 | Workshop

30 Minutes with MIT Startups: COVID-19 Disease Monitoring & Contact Tracing

Virtual Event

Join MIT Startup Exchange to hear from MIT-connected startups who are focusing efforts on aspects of COVID-19.

Filter Results